Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 5,826–5,850 of 7,816 matching trials · page 234 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Novel Retinal Imaging Biomarkers in Early Alzheimer's Disease NCT01937221 spectral-domain optical coherence tomography (SD-OCT) Runs in: United States · 1 site |
NA other |
COMPLETED | 60 | Duke University OTHER |
2019-01-31 |
|
Experience With a Robot for Home Care and Its Acceptance by People With Dementia, Caregivers and Dementia Trainers NCT03823066 Coach Pepper Runs in: Austria · 1 site |
NA other |
COMPLETED | 12 | Medical University of Graz OTHER |
2019-01-30 |
|
Effect of Donepezil on Cognition in Parkinson's Disease With Mild Cognitive Impairment (PD-MCI) NCT02450786 Donepezil Runs in: South Korea · 1 site |
PHASE2 symptomatic-cholinergic |
UNKNOWN | 80 | Yonsei University OTHER |
2019-01-29 |
|
Vildagliptin in Older Adults With Diabetes and Mild Cognitive Impairment NCT03819127 Vildagliptin 50 MG Oral Tablet; Metformin Pill |
PHASE4 other |
COMPLETED | 60 | University of Catania OTHER |
2019-01-28 |
|
Music for Dementia-related Sleep Problems NCT03445299 Music Runs in: Denmark · 1 site |
NA other |
COMPLETED | 40 | University of Aarhus OTHER |
2019-01-25 |
|
Wearable Sensors for Quantitative Assessment of Motor Impairment in Huntington's Disease Huntington's Disease NCT03599076 HD Wear Runs in: United States · 1 site |
NA other |
UNKNOWN | 50 | BioSensics INDUSTRY |
2019-01-24 |
|
Indiana University Dementia Screening Trial NCT01699503 Collaborative Dementia Care Program Runs in: United States · 3 sites |
NA other |
COMPLETED | 4,005 | Indiana University OTHER |
2019-01-23 |
|
The Benefits of the Use of the Feuerstein Cognitive Training Method on Cognitive Function in Community-dwelling Older Patients With Mild Cognitive Impairment: a Pilot Study NCT02388451 Feuerstein Program Runs in: Israel · 1 site |
NA other |
COMPLETED | 11 | Meir Medical Center OTHER |
2019-01-23 |
|
Clinical Characteristics of Dementias That Occur Remotely After Traumatic Brain Injury in Retired Military Personnel NCT01891383 Runs in: United States · 2 sites |
NA other |
WITHDRAWN | 0 | Uniformed Services University of the Health Sciences OTHER_GOV |
2019-01-18 |
|
Support Monitoring and Reminder Technology NCT03325699 SMART4MD Health Application Runs in: Belgium; Czechia; Spain; Sweden · 5 sites |
NA other |
UNKNOWN | 1,200 | Johan Sanmartin Berglund OTHER |
2019-01-17 |
|
ReMindCare App for Patients From First Episode of Psychosis Unit. NCT03807388 ReMindCare Intervention Group; Treatment as Usual Runs in: Spain · 1 site |
NA other |
UNKNOWN | 140 | Instituto de Investigacion Sanitaria INCLIVA OTHER |
2019-01-16 |
|
A Study of EGb 761® (Tanakan®) in Dementia of Alzheimer Type Onset in Patients Suffering From Memory Complaints NCT00276510 EGb 761® (Tanakan®); Placebo Runs in: France · 698 sites |
PHASE4 other |
COMPLETED | 2,878 | Ipsen INDUSTRY |
2019-01-15 |
|
Study Exploring Safety, Pharmacokinetic and Pharmacodynamic of BN82451 in Male Huntington's Disease Patients NCT02231580 BN82451B; Placebo Runs in: Germany · 1 site |
PHASE2 other |
TERMINATED | 17 | Ipsen INDUSTRY |
2019-01-15 |
|
The Cognitive and Cardiovascular Health in the Elderly Study NCT01979432 Cardiovascular evaluation Runs in: France · 1 site |
NA other |
TERMINATED | 17 | University Hospital, Limoges OTHER |
2019-01-11 |
|
A Cognitive Training Tool Based on Life-logging in Mild Cognitive Impairment (ReMemory-MCI) NCT02592187 ReMemory-MCI training; Control intervention |
NA other |
UNKNOWN | 30 | Consorci Sanitari de Terrassa OTHER |
2019-01-11 |
|
Brain Changes With Game Training in Aging NCT02490137 Race Car Video Game Runs in: United States · 1 site |
NA other |
COMPLETED | 20 | University of Wisconsin, Madison OTHER |
2019-01-10 |
|
Pharmaceutical Collaborative Care Integrated to a Multidisciplinary Psychosocial Program NCT02802371 Psychosocial intervention; Pharmaceutical care and psychosocial support Runs in: France · 1 site |
NA other |
UNKNOWN | 240 | Hospices Civils de Lyon OTHER |
2019-01-10 |
|
Natural History of Amyloid Deposition in Adults With Down Syndrome NCT01303133 Runs in: United States · 2 sites |
NA other |
COMPLETED | 81 | University of Pittsburgh OTHER |
2019-01-09 |
|
A Post-Marketing Clinical Study of Aricept in Patients With Dementia With Lewy Bodies (DLB) NCT02345213 E2020; Placebo Runs in: Japan · 1 site |
PHASE4 other |
COMPLETED | 160 | Eisai Co., Ltd. INDUSTRY |
2019-01-08 |
|
Triggered Palliative Care for Advanced Dementia NCT02719938 Specialty Palliative Care Runs in: United States · 1 site |
NA other |
COMPLETED | 62 | University of North Carolina, Chapel Hill OTHER |
2019-01-08 |
|
Donepezil and the Risk of Falls in Seniors With Cognitive Impairment NCT00934531 Donepezil Runs in: Canada · 1 site |
NA symptomatic-cholinergic |
COMPLETED | 60 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's OTHER |
2019-01-07 |
|
Study of Degenerescence CSF Hallmarks in Older Bipolar Patients NCT02836054 lumbar puncture (LP); brain MRI Runs in: France · 1 site |
NA other |
UNKNOWN | 30 | University Hospital, Grenoble OTHER |
2019-01-07 |
|
Evaluation of [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948 as Tracers for Positron Emission Tomography (PET) Imaging of Tau in Healthy and Alzheimer's Disease (AD) Participants NCT02187627 [11C]RO6924963; [11C]RO6931643; [18F]RO6958948 Runs in: United States · 2 sites |
PHASE1 other |
COMPLETED | 52 | Hoffmann-La Roche INDUSTRY |
2019-01-02 |
|
Evaluate the Safety and Efficacy of AD-35 Tablet in Subjects With Mild to Moderate Alzheimer's Disease NCT03790982 Placebo of AD-35 60mg /AD-35 30mg; Placebo of AD-35 60mg /AD-35 60m... Runs in: China · 1 site |
PHASE2 other |
UNKNOWN | 240 | Zhejiang Hisun Pharmaceutical Co. Ltd. INDUSTRY |
2019-01-02 |
|
A Study on the Effectiveness of Multidomain Intervention Program for Reducing Risks of Dementia NCT03786510 Active control; Intensive + Maintenance program; Intensive program only Runs in: South Korea · 1 site |
NA other |
COMPLETED | 32 | Seoul National University Hospital OTHER |
2018-12-26 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial